SOX9-AS1 dysregulation in SSc skin may represent one mechanism by which SOX9 levels are elevated in SSc tissues, and IGF-II induction of SOX9 expression provides yet another mechanism. This evidence concerns the gene IGF2 and systemic sclerosis.